(Q72861536)
Statements
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate (English)
F Levi
B Perpoint
C Garufi
C Focan
P Chollet
P Depres-Brummer
R Zidani
S Brienza
M Itzhaki
1 January 1993